FOCUS: PCC + Bevacizumab + CA4P Versus PCC + Bevacizumab + Placebo for Subjects With Platinum Resistant Ovarian Cancer

Clinical trial NCT02641639 · TERMINATED

Trial details

NCT number: NCT02641639
Sponsor: Mateon Therapeutics
Status: TERMINATED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Platinum Resistant Ovarian Cancer

Start date: 2016-06-01
Primary completion: 2017-10-01
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.